Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001172661-16-002634
Filing Date
2016-02-12
Accepted
2016-02-12 15:10:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G insm123115.htm SC 13G 91398
  Complete submission text file 0001172661-16-002634.txt   92970
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

EIN.: 133976876 | State of Incorp.: DE
Type: SC 13G

Mailing Address 10 FINDERNE AVENUE BUILDING 10 BRIDGEWATER NJ 08807
Business Address 10 FINDERNE AVENUE BUILDING 10 BRIDGEWATER NJ 08807 908-977-9900
INSMED Inc (Subject) CIK: 0001104506 (see all company filings)

EIN.: 541972729 | State of Incorp.: VA | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-59149 | Film No.: 161418246
SIC: 2834 Pharmaceutical Preparations